LPAR2 and renal carcinoma: Hashimoto et al. revealed that high expression or simultaneous high ASAP1 expression with erythrocyte membrane protein band 4.1 like 5 (EPB41L5) and lysophosphatidic acid receptor 2 (LPAR2) in renal cancer inidicates a poor prognosis (16).